[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,370
Citations 0
Correction
March 1, 2016

Coordinating Clinical Site Omitted

JAMA. 2016;315(9):944. doi:10.1001/jama.2016.1591

In the Original Investigation entitled “Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial” published in the November 24, 2015, issue of JAMA,1 a coordinating clinical site was omitted from eAppendix 1 in Supplement 1: Grand Blanc, MI Retina Vitreous Center (4): Robin D. Ross (I); Susan M. Sanford (C); Nicole Martini Markiewicz (C); Tracy M. Utley (C,V); Shannon Henderson (V); Mary D. Walker (V); Joanie H. Lippincott (P); Patricia Streasick (P). This article was corrected online.

References
1.
Gross  JG, Glassman  AR, Jampol  LM,  et al; Writing Committee for the Diabetic Retinopathy Clinical Research Network.  Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA. 2015;314(20):2137-2146.
PubMedArticle
×